Related Experiment Video
Updated: Jun 20, 2026
11:48
Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Variant-specific SF3B1 mutations drive distinct splicing and mitochondrial dysfunction in myelodysplastic neoplasms
Andrea Hruštincová1, Iva Trsová1,2, David Kundrát1
1Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
Human Genomics
|June 19, 2026
Summary
SF3B1 mutations in myelodysplastic neoplasms (MDS) have varied clinical outcomes. The K666N variant, unlike K700E, shows adverse prognosis and mitochondrial dysfunction, suggesting targeted therapies.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- SF3B1 spliceosome mutations are common in myelodysplastic neoplasms (MDS).
- The K700E variant typically indicates a favorable prognosis.
- The clinical impact of other SF3B1 variants remains unclear.
Purpose of the Study:
- To investigate the clinical, transcriptomic, and functional effects of different SF3B1 mutations in MDS.
- To compare the consequences of SF3B1 K700E, K666, and H662 variants.
Main Methods:
- Analysis of clinical data from 121 MDS patients with SF3B1 mutations.
- RNA sequencing of patient CD34+ cells and isogenic cell models with specific SF3B1 variants.
- Comprehensive profiling of splicing, gene expression, and mitochondrial function.
Main Results:
- The SF3B1 K666 variant correlated with shorter progression-free survival and distinct splicing defects compared to K700E.
- Mitochondria-related genes showed aberrant splicing and expression in K666-variant cells.
- K666N variant induced significant mitochondrial oxidative phosphorylation (OXPHOS) impairment and adverse prognosis.
Conclusions:
- SF3B1-mutated MDS is a heterogeneous disease with variant-specific effects.
- Mitochondrial dysfunction associated with specific SF3B1 variants presents potential therapeutic targets.
Related Concept Videos
01:32RNA Splicing
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
01:32RNA Splicing
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
02:18Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:39Mutations
Overview